Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 22:41:05 UTC |
---|
Update Date | 2022-11-23 22:29:21 UTC |
---|
HMDB ID | HMDB0259781 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | Veratramine |
---|
Description | 2-(1-{3-hydroxy-10,11b-dimethyl-1H,2H,3H,4H,6H,6aH,11H,11aH,11bH-cyclohexa[a]fluoren-9-yl}ethyl)-5-methylpiperidin-3-ol belongs to the class of organic compounds known as fluorenes. Fluorenes are compounds containing a fluorene moiety, which consists of two benzene rings connected through either a cyclopentane, cyclopentene, or cyclopenta-1,3-diene. Based on a literature review very few articles have been published on 2-(1-{3-hydroxy-10,11b-dimethyl-1H,2H,3H,4H,6H,6aH,11H,11aH,11bH-cyclohexa[a]fluoren-9-yl}ethyl)-5-methylpiperidin-3-ol. This compound has been identified in human blood as reported by (PMID: 31557052 ). Veratramine is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Veratramine is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | CC(C1NCC(C)CC1O)C1=CC=C2C3CC=C4CC(O)CCC4(C)C3CC2=C1C InChI=1S/C27H39NO2/c1-15-11-25(30)26(28-14-15)17(3)20-7-8-21-22-6-5-18-12-19(29)9-10-27(18,4)24(22)13-23(21)16(20)2/h5,7-8,15,17,19,22,24-26,28-30H,6,9-14H2,1-4H3 |
---|
Synonyms | Not Available |
---|
Chemical Formula | C27H39NO2 |
---|
Average Molecular Weight | 409.614 |
---|
Monoisotopic Molecular Weight | 409.2980795 |
---|
IUPAC Name | 2-(1-{5-hydroxy-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-7,11,13,15-tetraen-14-yl}ethyl)-5-methylpiperidin-3-ol |
---|
Traditional Name | veratramine |
---|
CAS Registry Number | Not Available |
---|
SMILES | CC(C1NCC(C)CC1O)C1=CC=C2C3CC=C4CC(O)CCC4(C)C3CC2=C1C |
---|
InChI Identifier | InChI=1S/C27H39NO2/c1-15-11-25(30)26(28-14-15)17(3)20-7-8-21-22-6-5-18-12-19(29)9-10-27(18,4)24(22)13-23(21)16(20)2/h5,7-8,15,17,19,22,24-26,28-30H,6,9-14H2,1-4H3 |
---|
InChI Key | MALFODICFSIXPO-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as fluorenes. Fluorenes are compounds containing a fluorene moiety, which consists of two benzene rings connected through either a cyclopentane, cyclopentene, or cyclopenta-1,3-diene. |
---|
Kingdom | Organic compounds |
---|
Super Class | Benzenoids |
---|
Class | Fluorenes |
---|
Sub Class | Not Available |
---|
Direct Parent | Fluorenes |
---|
Alternative Parents | |
---|
Substituents | - Fluorene
- Indane
- Aralkylamine
- Piperidine
- Cyclic alcohol
- 1,2-aminoalcohol
- Secondary alcohol
- Secondary aliphatic amine
- Azacycle
- Organoheterocyclic compound
- Secondary amine
- Organonitrogen compound
- Hydrocarbon derivative
- Organopnictogen compound
- Organic nitrogen compound
- Organic oxygen compound
- Organooxygen compound
- Alcohol
- Amine
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
VERATRAMINE,3TMS,isomer #1 | CC1=C(C(C)C2C(O[Si](C)(C)C)CC(C)CN2[Si](C)(C)C)C=CC2=C1CC1C2CC=C2CC(O[Si](C)(C)C)CCC21C | 3482.3 | Semi standard non polar | 33892256 | VERATRAMINE,3TMS,isomer #1 | CC1=C(C(C)C2C(O[Si](C)(C)C)CC(C)CN2[Si](C)(C)C)C=CC2=C1CC1C2CC=C2CC(O[Si](C)(C)C)CCC21C | 3621.7 | Standard non polar | 33892256 | VERATRAMINE,3TMS,isomer #1 | CC1=C(C(C)C2C(O[Si](C)(C)C)CC(C)CN2[Si](C)(C)C)C=CC2=C1CC1C2CC=C2CC(O[Si](C)(C)C)CCC21C | 3879.7 | Standard polar | 33892256 | VERATRAMINE,3TBDMS,isomer #1 | CC1=C(C(C)C2C(O[Si](C)(C)C(C)(C)C)CC(C)CN2[Si](C)(C)C(C)(C)C)C=CC2=C1CC1C2CC=C2CC(O[Si](C)(C)C(C)(C)C)CCC21C | 4050.9 | Semi standard non polar | 33892256 | VERATRAMINE,3TBDMS,isomer #1 | CC1=C(C(C)C2C(O[Si](C)(C)C(C)(C)C)CC(C)CN2[Si](C)(C)C(C)(C)C)C=CC2=C1CC1C2CC=C2CC(O[Si](C)(C)C(C)(C)C)CCC21C | 4352.2 | Standard non polar | 33892256 | VERATRAMINE,3TBDMS,isomer #1 | CC1=C(C(C)C2C(O[Si](C)(C)C(C)(C)C)CC(C)CN2[Si](C)(C)C(C)(C)C)C=CC2=C1CC1C2CC=C2CC(O[Si](C)(C)C(C)(C)C)CCC21C | 4122.4 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Veratramine GC-MS (Non-derivatized) - 70eV, Positive | splash10-0006-1119000000-49646e86ad448bedd797 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Veratramine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Veratramine GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Veratramine GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Veratramine GC-MS (TMS_1_3) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Veratramine GC-MS (TMS_2_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Veratramine GC-MS (TMS_2_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Veratramine GC-MS (TMS_2_3) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Veratramine GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Veratramine GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Veratramine GC-MS (TBDMS_1_3) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Veratramine GC-MS (TBDMS_2_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Veratramine GC-MS (TBDMS_2_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Veratramine GC-MS (TBDMS_2_3) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum |
|
---|